Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1233 ARTÍCULOS , VIENDO DEL 961 AL 975

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12):4002. doi: 10.3390/ijms19124002.

Biological clocks, some clock-related diseases, and medicinal plants

Deng TS.

Psych J. 2018 Dec;7(4):197-205. doi: 10.1002/pchj.263.

Atypical PKC: therapeutic target for Alzheimer's?

Farese RV, Sajan MP.

Aging (Albany NY). 2018 Dec 20;11(1):13-14. doi: 10.18632/aging.101730.

Liposome delivery systems for the treatment of Alzheimer's disease

Ross C, Taylor M, Fullwood N, Allsop D.

Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018.

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials

Dou KX, Tan MS, Tan CC, Cao XP, Hou XH, Guo QH, Tan L, Mok V, Yu JT.

Alzheimers Res Ther. 2018 Dec 27;10(1):126. doi: 10.1186/s13195-018-0457-9.

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis

Kennedy RE, Cutter GR, Fowler ME, Schneider LS.

JAMA Netw Open. 2018 Nov 2;1(7):e184080. doi: 10.1001/jamanetworkopen.2018.4080.

Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation

Qazi TJ, Quan Z, Mir A, Qing H.

Mol Neurobiol. 2018 Feb;55(2):1026-1044. doi: 10.1007/s12035-016-0357-6. Epub 2017 Jan 14.

Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis

Zoltowska KM, Berezovska O.

Mol Neurobiol. 2018 Mar;55(3):2275-2284. doi: 10.1007/s12035-017-0487-5. Epub 2017 Mar 22.

Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease

Condello C, Stöehr J.

Neurobiol Dis. 2018 Jan;109(Pt B):191-200. doi: 10.1016/j.nbd.2017.03.014. Epub 2017 Mar 28.

Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential

de Matos AM, de Macedo MP, Rauter AP.

Med Res Rev. 2018 Jan;38(1):261-324. doi: 10.1002/med.21440. Epub 2017 Apr 19.

Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease

Zhao N, Liu CC, Qiao W, Bu G.

Biol Psychiatry. 2018 Feb 15;83(4):347-357. doi: 10.1016/j.biopsych.2017.03.003. Epub 2017 Mar 14.

Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations

Li K, Wei Q, Liu FF, Hu F, Xie AJ, Zhu LQ, Liu D.

Mol Neurobiol. 2018 Apr;55(4):3021-3032. doi: 10.1007/s12035-017-0533-3. Epub 2017 Apr 29.

Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review

Canhada S, Castro K, Perry IS, Luft VC.

Nutr Neurosci. 2018 Oct;21(8):529-538. doi: 10.1080/1028415X.2017.1321813. Epub 2017 May 3.

Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches

Corrêa-Velloso JC, Gonçalves MC, Naaldijk Y, Oliveira-Giacomelli Á, Pillat MM, Ulrich H.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt A):34-53. doi: 10.1016/j.pnpbp.2017.04.033. Epub 2017 May 3.

Amyloid is essential but insufficient for Alzheimer causation: addition of subcellular cofactors is required for dementia

Fessel J.

Int J Geriatr Psychiatry. 2018 Jan;33(1):e14-e21. doi: 10.1002/gps.4730. Epub 2017 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias